These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1340 related items for PubMed ID: 17145839

  • 1. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC, Ye SL, Sun RX, Liu YK, Tang ZY, Kim Y, Karras JG, Zhang H.
    Clin Cancer Res; 2006 Dec 01; 12(23):7140-8. PubMed ID: 17145839
    [Abstract] [Full Text] [Related]

  • 2. Regulation of angiogenesis by Id-1 through hypoxia-inducible factor-1alpha-mediated vascular endothelial growth factor up-regulation in hepatocellular carcinoma.
    Lee TK, Poon RT, Yuen AP, Ling MT, Wang XH, Wong YC, Guan XY, Man K, Tang ZY, Fan ST.
    Clin Cancer Res; 2006 Dec 01; 12(23):6910-9. PubMed ID: 17145808
    [Abstract] [Full Text] [Related]

  • 3. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y, Tang Y, Ye L, Liu B, Liu K, Chen J, Xue Q.
    J Cancer Res Clin Oncol; 2003 Jan 01; 129(1):43-51. PubMed ID: 12618900
    [Abstract] [Full Text] [Related]

  • 4. Luteolin promotes degradation in signal transducer and activator of transcription 3 in human hepatoma cells: an implication for the antitumor potential of flavonoids.
    Selvendiran K, Koga H, Ueno T, Yoshida T, Maeyama M, Torimura T, Yano H, Kojiro M, Sata M.
    Cancer Res; 2006 May 01; 66(9):4826-34. PubMed ID: 16651438
    [Abstract] [Full Text] [Related]

  • 5. Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma.
    Wang Z, Zhou J, Fan J, Qiu SJ, Yu Y, Huang XW, Tang ZY.
    Clin Cancer Res; 2008 Aug 15; 14(16):5124-30. PubMed ID: 18698030
    [Abstract] [Full Text] [Related]

  • 6. Brivanib alaninate, a dual inhibitor of vascular endothelial growth factor receptor and fibroblast growth factor receptor tyrosine kinases, induces growth inhibition in mouse models of human hepatocellular carcinoma.
    Huynh H, Ngo VC, Fargnoli J, Ayers M, Soo KC, Koong HN, Thng CH, Ong HS, Chung A, Chow P, Pollock P, Byron S, Tran E.
    Clin Cancer Res; 2008 Oct 01; 14(19):6146-53. PubMed ID: 18829493
    [Abstract] [Full Text] [Related]

  • 7. Overexpression of platelet-derived growth factor receptor alpha in endothelial cells of hepatocellular carcinoma associated with high metastatic potential.
    Zhang T, Sun HC, Xu Y, Zhang KZ, Wang L, Qin LX, Wu WZ, Liu YK, Ye SL, Tang ZY.
    Clin Cancer Res; 2005 Dec 15; 11(24 Pt 1):8557-63. PubMed ID: 16361537
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic effects of STAT3 decoy oligodeoxynucleotide on human lung cancer in xenograft mice.
    Zhang X, Zhang J, Wang L, Wei H, Tian Z.
    BMC Cancer; 2007 Aug 04; 7():149. PubMed ID: 17683579
    [Abstract] [Full Text] [Related]

  • 9. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.
    Chen RX, Xia YH, Xue TC, Zhang H, Ye SL.
    Oncol Rep; 2011 Mar 04; 25(3):803-8. PubMed ID: 21174062
    [Abstract] [Full Text] [Related]

  • 10. [Inhibition of growth and metastasis of hepatocellular carcinoma by rapamycin: experiment with mice].
    Wang Z, Fan J, Zhou J, Wu ZQ, Qiu SJ, Yu Y, Huang XW, Tang ZY.
    Zhonghua Yi Xue Za Zhi; 2006 Jun 27; 86(24):1666-70. PubMed ID: 16854316
    [Abstract] [Full Text] [Related]

  • 11. Suppression of liver tumor growth and metastasis by adiponectin in nude mice through inhibition of tumor angiogenesis and downregulation of Rho kinase/IFN-inducible protein 10/matrix metalloproteinase 9 signaling.
    Man K, Ng KT, Xu A, Cheng Q, Lo CM, Xiao JW, Sun BS, Lim ZX, Cheung JS, Wu EX, Sun CK, Poon RT, Fan ST.
    Clin Cancer Res; 2010 Feb 01; 16(3):967-77. PubMed ID: 20103676
    [Abstract] [Full Text] [Related]

  • 12. New human hepatocellular carcinoma (HCC) cell line with highly metastatic potential (MHCC97) and its expressions of the factors associated with metastasis.
    Tian J, Tang ZY, Ye SL, Liu YK, Lin ZY, Chen J, Xue Q.
    Br J Cancer; 1999 Nov 01; 81(5):814-21. PubMed ID: 10555751
    [Abstract] [Full Text] [Related]

  • 13. Inhibition of invasion and metastasis of hepatocellular carcinoma cells via targeting RhoC in vitro and in vivo.
    Wang W, Wu F, Fang F, Tao Y, Yang L.
    Clin Cancer Res; 2008 Nov 01; 14(21):6804-12. PubMed ID: 18980974
    [Abstract] [Full Text] [Related]

  • 14. [Effects of STAT3 antisense oligonucleotide on proliferation and apoptosis of non-small cell lung cancer cell line A549].
    Zhu BR, Cai JM, Tang GS, Li BL, Gao F, Cui JG, Liu HC.
    Ai Zheng; 2007 Aug 01; 26(8):820-7. PubMed ID: 17697540
    [Abstract] [Full Text] [Related]

  • 15. Growth-inhibitory effects of human anti-insulin-like growth factor-I receptor antibody (A12) in an orthotopic nude mouse model of anaplastic thyroid carcinoma.
    Wang Z, Chakravarty G, Kim S, Yazici YD, Younes MN, Jasser SA, Santillan AA, Bucana CD, El-Naggar AK, Myers JN.
    Clin Cancer Res; 2006 Aug 01; 12(15):4755-65. PubMed ID: 16899627
    [Abstract] [Full Text] [Related]

  • 16. Growth inhibition of human hepatocellular carcinoma cells by blocking STAT3 activation with decoy-ODN.
    Sun X, Zhang J, Wang L, Tian Z.
    Cancer Lett; 2008 Apr 18; 262(2):201-13. PubMed ID: 18248786
    [Abstract] [Full Text] [Related]

  • 17. Galiellalactone is a novel therapeutic candidate against hormone-refractory prostate cancer expressing activated Stat3.
    Hellsten R, Johansson M, Dahlman A, Dizeyi N, Sterner O, Bjartell A.
    Prostate; 2008 Feb 15; 68(3):269-80. PubMed ID: 18163422
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of Stat3 activation and tumor growth suppression of non-small cell lung cancer by G-quartet oligonucleotides.
    Weerasinghe P, Garcia GE, Zhu Q, Yuan P, Feng L, Mao L, Jing N.
    Int J Oncol; 2007 Jul 15; 31(1):129-36. PubMed ID: 17549413
    [Abstract] [Full Text] [Related]

  • 19. STAT3-targeting RNA interference inhibits pancreatic cancer angiogenesis in vitro and in vivo.
    Huang C, Jiang T, Zhu L, Liu J, Cao J, Huang KJ, Qiu ZJ.
    Int J Oncol; 2011 Jun 15; 38(6):1637-44. PubMed ID: 21479358
    [Abstract] [Full Text] [Related]

  • 20. GYY4137, a hydrogen sulfide (H₂S) donor, shows potent anti-hepatocellular carcinoma activity through blocking the STAT3 pathway.
    Lu S, Gao Y, Huang X, Wang X.
    Int J Oncol; 2014 Apr 15; 44(4):1259-67. PubMed ID: 24535538
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 67.